CIAS
HALO icon

Capital Investment Advisory Services’s Halozyme HALO Stock Holding History

Capital Investment Advisory Services’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-28
Closed – – 857
2019
Q3 		$0 Hold
28
– – ﹤0.01% 1406
2019
Q2 		$0 Hold
28
– – ﹤0.01% 1420
2019
Q1 		$0 Hold
28
– – ﹤0.01% 1232
2018
Q4 		$0 Buy
+28
New +$447 ﹤0.01% 1201

Other funds holding HALO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Capital Investment Advisory Services's HALO Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Halozyme (HALO) in Q4 2019, closing a stake of 28 shares.

Capital Investment Advisory Services first reported a position in HALO in Q4 2018 and held it in 4 quarters. The position peaked at $0 in Q3 2019. 224 funds tracked by Wall St. Rank hold HALO as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Halozyme position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 28 Halozyme shares in Q4 2019.
  • Capital Investment Advisory Services first reported a position in Halozyme in Q4 2018 and held it in 4 quarters.
  • Capital Investment Advisory Services's Halozyme position peaked at $0 in Q3 2019.
  • 224 funds tracked by Wall St. Rank held Halozyme as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.